Emergent Biosolutions (NYSE:EBS) on Tuesday held its 2026 Annual Meeting of Stockholders, where shareholders voted on ...

Detailed price information for Emergent Biosolutions (EBS-N) from The Globe and Mail including charting and trades.

Star left fielder joins forces with Emergent to educate the public on the importance of being prepared with NARCAN® Nasal SpraySchneider shares ...

Q1 2026 earnings call highlights: revenue, EBITDA, guidance, NARCAN and international MCM growth, plus debt moves—read now.

Emergent BioSolutions Inc. (NYSE: EBS) today announced that Singapore’s Health Sciences Authority (HSA) has approved an expanded indication for ACAM2000® (Smallpox and Mpox (Vaccinia) Vaccine, Live) ...

(NYSE: EBS) today reported financial results for the first quarter ended March 31, 2026. “Emergent’s first quarter results demonstrate a strong and positive start to 2026, with healthy topline revenue ...

Emergent Biosolutions ((EBS)) has held its Q3 earnings call. Read on for the main highlights of the call. Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, ...

Detailed price information for Emergent Biosolutions (EBS-N) from The Globe and Mail including charting and trades.

GAITHERSBURG — Emergent Biosolutions Inc. (EBS) on Wednesday reported a loss of $12 million in its second quarter. The Gaithersburg-based company said it had a loss of 22 cents per share. Earnings, ...

GAITHERSBURG, Md. (AP) — GAITHERSBURG, Md. (AP) — Emergent Biosolutions Inc. (EBS) on Thursday reported earnings of $6.8 million in its first quarter. The Gaithersburg, Maryland-based company said it ...

Emergent BioSolutions is partnering with British Columbia's health authority to supply Narcan nasal spray as part of the province's efforts to expand access to naloxone. Under the collaboration, ...